Published in Vaccine Weekly, September 4th, 1995
As reported in the August 17, 1995, Nature, Thomas A. Wynn, Ph.D., of the Immunobiology Section of NIAID's Laboratory of Parasitic Diseases, Alan Sher, Ph.D., chief of the Immunobiology Section, and their co-workers have developed an experimental vaccine for schistosomiasis based on a signalling molecule of the immune system, interleukin-12 (IL-12). In their experiments, the vaccine substantially reduced the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly